Start-Ups Swimming ...
Health Care: Drugs
Cornerstone Therapeutics Inc. (CRTX: NASDAQ)
$8.46 0.05 | 0.59%
05/24/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -11.89M | -693.00K | 6.17M | 10.20M |
| Operating Gains/Losses | -1.67M | 0.00 | 25.00K | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -741.00K | 61.13M | -63.83M | -6.72M |
| (Increase) Decrease in Inventories | -2.01M | 5.55M | 1.59M | -8.20M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -4.46M | -627.00K | 499.00K | -3.12M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | -16.82M | 21.35M | 722.00K |
| (Increase) Decrease In Other Working Capital | -1.50M | -55.77M | 57.19M | 0.00 |
| Other Non-Cash Items | 37.77M | 7.98M | 6.93M | 7.92M |
| Net Cash From Continuing Operations | 18.39M | 24.17M | 32.99M | 450.00K |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 18.39M | 24.17M | 32.99M | 450.00K |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 2.00K | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 300.00K |
| Purchases of Property, Plant & Equipment | -1.28M | -616.00K | -625.00K | -5.80M |
| Acquisitions | -126.92M | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 3.00M | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -125.20M | -616.00K | -623.00K | -5.50M |
| Issuance of Debt | 90.00M | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 1.16M | 369.00K | 544.00K | 15.90M |
| Repayment of Long-Term Debt | -92.00K | -1.42M | -1.30M | -2.51M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | -1.98M | 522.00K | 478.00K | 1.23M |
| Net Cash From Financing Activities | 89.09M | -533.00K | -274.00K | 14.62M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | -17.72M | 23.02M | 32.09M | 9.57M |
Portfolios with CRTX
- Portfolio NameUser Type
- ContributorDrugs Facing FDA Approval i...
- ContributorStocks Under-$10 Moving Hig...
- User0730
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Health-Care Stocks Outpe...
- Userrussbow98 Portfolio 1
- UserSUPRATRADE-2609091346
- UserShooting Stocks
- UserCREW
Latest CRTX Headlines from TheStreet
- Cornerstone Therapeutics Inc. Stock Upgraded (CRTX) 03.04.13 | 04:03 am
- 31 Drugs Facing FDA Approval in 2012-2013 08.20.12 | 08:08 am
- 5 Stocks Under $10 Set to Soar 07.26.12 | 12:07 pm
- 4 Biotech Stocks Under $10 With Relative Strength 07.24.12 | 02:07 pm
- Cornerstone Therapeutics Inc. Stock Downgraded (CRTX) 07.10.12 | 05:07 am
- Cornerstone Therapeutics Inc. Stock Downgraded (CRTX) 11.11.11 | 05:11 am
- Cornerstone Stock Soars (CRTX) 10.04.11 | 04:10 pm
- 10 Health-Care Stocks Outperforming the Index 06.07.11 | 01:06 pm
- Cornerstone Therapeutics Inc. Stock Upgraded (CRTX) 03.31.11 | 06:03 pm
- Momentum BioPharmaceutical Play: Stocks Under $10
03.31.11 | 06:03 am
Press Releases for CRTX
- SHAREHOLDER ALERT: The Law Firm Of Levi & Korsinsky, LLP Launches Investigation In Possible Breaches Of Fiduciary Duty By The Board Of Cornerstone Therapeutics, Inc. In Connection With A Going Private Proposal - Business Wire 02.25.13 | 06:02 pm
- Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of Cornerstone Therapeutics Inc. Shareholders - Business Wire 02.25.13 | 03:02 pm
- Cornerstone Therapeutics Shareholder Alert: Briscoe Law Firm And Powers Taylor, LLP Investigate Going Private Proposal - Business Wire 02.22.13 | 04:02 pm
- Cornerstone Therapeutics Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Chiesi Farmaceutici SpA's Going Private Offer - PR Newswire 02.21.13 | 09:02 am
- SHAREHOLDER ALERT: The Law Firm Of Levi & Korsinsky, LLP Launches Investigation In Possible Breaches Of Fiduciary Duty By The Board Of Cornerstone Therapeutics, Inc. In Connection With A Going Private Proposal - PR Newswire 02.20.13 | 10:02 am
- New Research Indicates Treating Neonatal Respiratory Distress Syndrome With CUROSURF® Results In Lower Rate Of Mortality Compared To Competitive Surfactants - Business Wire 09.12.11 | 08:09 am
- Cornerstone Therapeutics To Present At Rodman & Renshaw 12th Annual Healthcare Conference - PR Newswire 09.08.10 | 08:09 am
- Cornerstone Therapeutics Announces Development Of Generic For Tussionex® - PR Newswire 08.05.10 | 09:08 am
- Cornerstone Therapeutics Licenses Alpha-7 Technology To Targacept - PR Newswire 08.03.10 | 08:08 am
- Cornerstone Therapeutics Announces Collaboration With The Cough Company - PR Newswire 08.02.10 | 08:08 am
Partner Headlines for CRTX
- Bad News for Cornerstone - Analyst Blog - NASDAQ 09.20.12 | 09:09 pm
- Cornerstone Therapeutics, Inc. Enters Oversold Territory - Tale of the Tape - NASDAQ 09.10.12 | 02:09 pm
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - NASDAQ 08.30.12 | 12:08 pm
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 08.30.12 | 09:08 am
- Zacks #5 Rank Additions for Tuesday - Tale of the Tape - Zacks 03.20.12 | 09:03 am
- 10 Biotech Stocks Undervalued By Levered Free Cash Flows - Seeking Alpha 12.07.11 | 08:12 am
- Rio Tinto Gets Approval for Chinalco Mineral Exploration in China - NASDAQ 11.25.11 | 08:11 am
- Cornerstone Therapeutics to withdraw three painkillers - Reuters 11.22.10 | 11:11 am
- Cornerstone Tops Consensus - Analyst Blog - Zacks 03.08.10 | 12:03 pm
